ANSELL LIMITED — Capital/Financing Update 2013

Nov 26, 2013

PRESS RELEASE

==> picture [103 x 32] intentionally omitted <==

For Immediate Release 27 November 2013 Not for release in the United States

For more information: Ansell Limited A.C.N. 004 085 330 Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia GPO Box 772H, Melbourne, Victoria 3001, Australia Telephone (+61 3) 9270 7270 Facsimile (+61 3) 9270 7300 news@ansell.com

SUCCESSFUL COMPLETION OF ANSELL LIMITED'S A$338 MILLION PLACEMENT

Ansell Limited (ASX:ANN) (Ansell) today announces the successful completion of the fully underwritten placement to sophisticated and institutional investors to raise approximately A$338 million, as announced on 26 November 2013 (the Placement).

The Placement was oversubscribed at a price of $18.50 per new share, which represents a 4.9% discount to the closing price on 25 November 2013.

A total of approximately 18.2 million new shares will be issued under the Placement, and these will rank equally with existing shares. The proceeds from the Placement will be used to partially fund the acquisition of BarrierSafe as announced on 26 November 2013 (the Acquisition), assuming regulatory approvals are obtained and the transaction completes. BarrierSafe is a leading North American provider of single use gloves with flagship brands including Microflex® and Onguard®.

Ansell is also conducting a share purchase plan (SPP) that will provide all eligible Australian and New Zealand shareholders the opportunity to apply for a parcel of new shares at the lower of the Placement price and a 2.5% discount to the volume weighted average trading price of Ansell shares in the last five trading days of the SPP offer period. Details of the SPP will be sent to eligible shareholders on or around 3 December 2013. The SPP will not be offered outside of Australia or New Zealand.

Ansell's Chief Financial Officer, Mr Neil Salmon, said, "We are delighted with the very strong level of support for the offer shown by Ansell's existing and new institutional shareholders globally. The share purchase plan will provide Ansell shareholders the opportunity to apply for new shares at the same or a lower price as institutional investors. Excess funds raised via the SPP will support the group's liquidity and further growth initiatives."

Further details on the Acquisition are contained in Ansell's investor presentation lodged with the ASX on 26 November 2013.

The trading halt is expected to be lifted prior to market open today. Settlement of the Placement is expected on Monday 2 December 2013, with allotment expected on Tuesday 3 December 2013.

UBS AG, Australia Branch acted as Sole Lead Manager and Underwriter to the Placement.

For further enquiries, please contact:

Investors and Analysts

Australia: David Graham, I.R.

Tel: (+613) 9270 7215

david.graham@ansell.com

Media

Australia: Helen McCombie, Citadel Tel: (614)11 756 248 Peter Bookes, Citadel Tel: (614)07 911 389

hmccombie@citadelpr.com.au pbrookes@citadelpr.com.au

About the Placement and SPP

Further information in relation to the specific details of the Placement and SPP described in this announcement including important notices and key risks in relation to certain forward looking information is set out in an investor presentation released on 26 November 2013 by Ansell. The information in the ‘Important Notice and Disclaimer’ and ‘Key Risks’ sections of the investor presentation applies to this announcement as if set out in full in this announcement. This press release includes “forward looking statements” within the meaning of securities laws of applicable jurisdictions. Forward looking statements can generally be identified by the use of the words “anticipate”, “believe”, “expect”, “project”, “forecast”, “estimate”, “likely”, “intend”, “should”, “could”, “may”, “target”, “plan” “guidance” and other similar expressions. Indications of, and guidance on, future earning or distributions and financial position and performance are also forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Ansell, and its officers, employees, agents or associates, that may cause actual results to differ materially from those expressed or implied in such statement. Actual results, performance or achievements may vary materially from any projections and forward looking statements and the assumptions on which those statements are based. Readers are cautioned not to place undue reliance on forward looking statements and Ansell assumes no obligation to update such information.

Important Notice

This announcement has been prepared for publication in Australia and may not be released in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. The securities offered and sold in the Placement have not been, and will not be, registered under the U.S. Securities Act of 1933 (“US Securities Act”) and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and applicable US state securities laws. The securities to be offered and sold in the SPP will only be offered and sold to eligible shareholders in Australia and New Zealand in offshore transactions in reliance on Regulation S under the US Securities Act.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being.

With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 13,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.

Information on Ansell and its products can be found at www.ansell.com.

==> picture [53 x 20] intentionally omitted <==

==> picture [35 x 21] intentionally omitted <==

==> picture [61 x 13] intentionally omitted <==

==> picture [38 x 12] intentionally omitted <==

® are trademarks owned by Ansell Limited or one of its affiliates. © 2013 Ansell Limited. All Rights Reserved.

2